For decades, parents of myopic children faced a difficult reality. While glasses and contact lenses could correct their child’s blurry distance vision, nothing could slow the underlying progression. Every year brought stronger prescriptions, and with each passing diopter came exponentially higher lifetime risks of retinal detachment, glaucoma, and macular degeneration. But the landscape of pediatric eye care has changed dramatically in recent years, and the latest innovation to join the arsenal of myopia management tools is transforming how we protect children’s vision.

FDA Authorization of Stellest Spectacle Lenses

The FDA authorization of Stellest spectacle lenses in September 2025 represents a watershed moment for families. For the first time, parents can access clinically proven myopia control technology in a familiar format that children as young as six can wear comfortably for 12 or more hours each day. This addition expands the treatment options available at practices dedicated to slowing childhood myopia progression, offering families a fourth modality alongside orthokeratology, multifocal soft contact lenses, and low-dose atropine therapy. Each option brings unique advantages, and understanding how they compare helps families choose the path that best fits their child’s lifestyle, maturity level, and clinical needs.

Understanding the Myopia Epidemic and Why Treatment Matters

How Common Is Childhood Myopia?

Myopia rates have skyrocketed from 25% of Americans in the 1970s to more than 42% today, and projections suggest that by 2050, nearly 58% of the global population will be myopic. Among children, the statistics are even more alarming. Studies tracking hundreds of thousands of American children show that myopia prevalence climbs from 14.7% at ages five through seven to 59% by ages 17 through 19. High myopia, defined as greater than negative five diopters, increases nearly tenfold across the same age range.

Why Is Progressive Myopia More Than Just Needing Stronger Glasses?

These numbers matter because myopia is not just a refractive inconvenience requiring stronger glasses. Progressive myopia is a disease process that physically elongates the eye, stretching the delicate tissues inside and dramatically increasing the risk of sight-threatening conditions later in life. Moderate myopia, ranging from negative three to negative five diopters, carries a ninefold higher risk of retinal detachment, a tenfold higher risk of myopic macular degeneration, triple the risk of cataracts, and double the risk of glaucoma compared to eyes with normal vision.

What Happens When Myopia Reaches High Levels?

When myopia progresses to high levels beyond negative five diopters, the risks become even more severe. Retinal detachment risk jumps to 21 times higher, macular degeneration to 40 times higher, cataracts to five times higher, and glaucoma to three times higher.

Does Every Diopter Really Matter?

The incremental nature of myopia progression masks its cumulative danger. Every additional diopter increases retinal detachment risk by 30%, macular degeneration by 67%, and glaucoma by 20%. Conversely, slowing progression by just one diopter reduces the risk of myopic maculopathy by 40% and retinal detachment by roughly 30%. The stakes are high, the window of intervention is narrow, and parents now have more tools than ever to protect their children’s visual future.

The Four Pillars of Myopia Management: A Personalized Approach

Modern myopia management recognizes that no single treatment fits every child. Age, maturity, prescription, lifestyle, family dynamics, and individual response all influence which approach will deliver the highest compliance and the strongest clinical outcome. The four primary modalities available today are orthokeratology, multifocal soft contact lenses, low-dose atropine eye drops, and now Stellest spectacle lenses. Each has been validated through rigorous clinical trials and offers meaningful reductions in myopia progression.

Orthokeratology: Overnight Reshaping for Daytime Freedom

How Does Ortho-K Work?

Orthokeratology, commonly called Ortho-K, involves wearing custom-designed rigid gas-permeable lenses overnight. While the child sleeps, these lenses gently reshape the cornea’s curvature, temporarily correcting the refractive error. Upon waking, the lenses are removed, and the child enjoys clear vision throughout the day without glasses or daytime contacts. This reshaping effect also creates peripheral signals that slow axial elongation of the eye, the underlying mechanism driving myopia progression.

What Do the Clinical Studies Show?

Clinical trials including the ROMIO Study, LORIC Study, CRAYON Study, COOKI Study, and CONTROL Study have demonstrated that Ortho-K slows myopic progression by 36% to 56% compared to children wearing standard spectacles or contact lenses. The treatment is FDA authorized for overnight wear and safe for all ages. More than one million people worldwide use orthokeratology regularly, and most children see significant results within two weeks.

Who Is the Best Candidate for Ortho-K?

Ortho-K appeals particularly to active children, athletes, and swimmers who want freedom from daytime correction. It eliminates the need to worry about glasses during sports or contacts drying out during long school days. However, success depends on consistent nightly wear and proper lens care, making it best suited for responsible children and engaged families who can support the routine. The technology also offers advanced customization, including wavefront-guided designs that optimize the optical profile for each individual eye.

Multifocal Soft Contact Lenses: Daily Disposables with Dual Focus

What Makes These Contact Lenses Different?

Multifocal soft contact lenses designed specifically for myopia control represent another breakthrough in pediatric vision care. These lenses are worn during the day and discarded at night, offering a fresh, hygienic lens every morning. The optical design features a central zone for clear distance vision surrounded by peripheral zones that create controlled myopic defocus. This defocus signals the eye to slow its growth, reducing axial elongation and progression.

How Effective Are MiSight Lenses?

MiSight 1 day lenses hold the distinction of being the first and only FDA-authorized contact lens clinically proven to slow myopia progression in children. Three-year clinical trials demonstrated a 59% reduction in refractive progression and a 52% reduction in axial length growth compared to children wearing single-vision lenses.

Do Kids Actually Like Wearing Them?

Child satisfaction rates are impressive, with 90% of children preferring MiSight over glasses and 90% able to insert and remove the lenses independently. Kids report seeing well during schoolwork, playing outdoors, and using computers or video games.

Who Should Consider Daily Multifocal Lenses?

These lenses are ideal for children ages eight and older who are ready to handle daily lens insertion and removal responsibly. They suit kids who want the convenience of contact lenses without committing to overnight wear. The daily disposable format minimizes infection risk and eliminates the need for cleaning solutions, making compliance straightforward. However, they do require daytime wear, which may be less convenient for certain water sports or activities where lenses could be dislodged.

Low-Dose Atropine: The Pharmacological Approach

What Is Atropine and How Does It Work?

Low-dose atropine eye drops offer a non-optical approach to myopia management. Atropine is an anticholinergic agent that has been used medically for nearly 100 years. At diluted concentrations of 0.01% to 0.05%, far lower than the doses used for dilated eye exams, atropine slows axial elongation and myopia progression. Parents administer one drop nightly to each eye, making it one of the simplest treatment regimens.

What Does the Research Say About Atropine?

The scientific foundation for atropine is robust. The landmark ATOM2 Study demonstrated efficacy at low doses with minimal side effects. The Low-Concentration Atropine for Myopia Progression (LAMP) Study, a randomized double-masked trial involving 350 children ages four to twelve, validated efficacy at concentrations of 0.05%, 0.025%, and 0.01%. A 2020 meta-analysis of ten randomized controlled trials involving more than 1,600 children found that low-dose atropine reduced myopia progression with a mean difference of negative 0.80 diopters and axial elongation by negative 0.26 millimeters compared to control groups.^[6]^[4]^[3]

A 2022 meta-analysis of twelve randomized trials and fifteen cohort studies involving more than 5,000 children confirmed that low-dose atropine showed better efficacy in the second year of treatment and had the smallest rebound effect after ceasing therapy. Efficacy with low-dose atropine typically ranges from 50% to 60% reduction in progression.

Are There Side Effects Parents Should Know About?

The safety profile is excellent. A 2021 clinical trial of 400 children over two years found that 23% to 24% experienced photophobia in bright sunlight during the first year, easily managed with sunglasses or hats. By the second year, no children reported discomfort, and none showed allergic reactions.

Which Children Benefit Most from Atropine?

This makes atropine particularly appealing for very young children under six who are not yet ready for contact lenses, for children with sensory sensitivities to lens wear, and for fast progressors who may benefit from combination therapy pairing atropine with an optical modality.

Stellest Spectacle Lenses: Simplicity Meets Innovation

What Are Stellest Lenses?

Children’s eyes are smaller than adults’, so standard 14 mm lenses can feel bulky and move around. Custom pediatric lenses, usually 13–13.6 mm, match a child’s corneal size and eyelid opening, making them far more comfortable from the very first blink.

How Well Do Stellest Lenses Work?

Clinical trials conducted in the United States involving children ages six to twelve with myopia ranging from negative 0.75 to negative 4.50 diopters demonstrated remarkable efficacy. In a randomized, double-masked two-year trial, Stellest wearers showed 71% less refractive progression and 53% less eye-length growth compared to children wearing single-vision lenses.

How Many Hours Per Day Should Children Wear Them?

The critical factor is consistent wear time. Clinical data indicates that children who wear Stellest lenses at least 12 hours per day, six days per week, achieve maximum therapeutic benefit. Longer daily wear correlates with better outcomes.

Are They Safe for Active Kids?

Stellest lenses are constructed from polycarbonate, a lightweight, impact-resistant material that offers 100% ultraviolet protection and includes an anti-smudge coating. This makes them safe for active kids who run, play, and engage in school activities. For contact or high-speed sports where glasses could be a liability, some families keep a spare pair of single-vision glasses or use contact lenses for the event, then resume Stellest immediately afterward.

When Did Stellest Receive FDA Authorization?

The lenses received FDA authorization under the De Novo pathway in September 2025, making them the first spectacle lens authorized specifically to help slow myopia progression in children.

Which Children Are Good Candidates?

Stellest lenses are ideal for children ages six to twelve, particularly those who are not yet ready for contact lenses, who have sensory sensitivities, or who simply prefer the familiarity and simplicity of glasses. They replace standard single-vision lenses, correcting vision immediately while providing therapeutic benefit over months and years of consistent wear. Fitting requires precise measurements including monocular pupillary distances and pupil-center heights, along with frame selection that minimizes pantoscopic tilt and wrap angles to ensure optimal optical alignment.

Why Stellest Expands Choices in Meaningful Ways

What Gap Does Stellest Fill?

Before Stellest, parents of young children faced a choice between optical treatments requiring lens handling (Ortho-K or multifocal soft lenses) or a pharmacological approach with eye drops (atropine). Some children, particularly those between ages six and eight, may not yet be mature enough to handle contact lens insertion and removal independently. Others have sensory processing challenges that make lens wear uncomfortable. Still others may have minor corneal irregularities or dry eye that complicates lens fitting. For these families, atropine was often the default, but it required nightly administration and offered no daytime vision correction, meaning the child still needed glasses anyway.

How Does Stellest Simplify Treatment?

Stellest fills this gap by delivering both vision correction and myopia control in a single spectacle. A six-year-old who wears Stellest gets clear vision all day, along with proven slowing of eye elongation, without needing to touch their eyes or remember drops each night. This simplicity removes barriers to compliance, which is critical because myopia management requires sustained treatment over years. The longer the child stays in treatment during the active growth years, the more diopters are saved, and the lower their lifetime disease risk.

Can Stellest Be Combined With Other Treatments?

Stellest also offers flexibility in combination therapy. For children whose myopia progresses rapidly despite a single modality, doctors may consider pairing Stellest with low-dose atropine, or transitioning to Ortho-K at night while using Stellest for backup daytime correction. This layered approach maximizes efficacy for fast progressors, giving clinicians and families more tools to customize treatment intensity. The ability to adjust strategies based on six-month progress checks allows for responsive, data-driven care.

Comparing the Options: Helping Families Decide

Each of the four myopia management modalities brings distinct advantages, and the optimal choice depends on the individual child and family. Parents often ask how they should decide, and the answer lies in considering several key factors together.

When Is Ortho-K the Best Choice?

Ortho-K offers the strongest appeal for active, athletic children who want complete freedom from daytime correction. Swimmers, gymnasts, soccer players, and outdoor enthusiasts benefit from waking up with clear vision and not worrying about glasses or lenses during the day. The 36% to 56% efficacy range is robust, and the overnight routine becomes habitual for most families within a few weeks. However, it requires the highest level of lens care and responsibility, so it is best suited for children eight and older, or for younger children with highly engaged parents who can supervise the routine.

What Makes Multifocal Soft Lenses Different?

Multifocal soft contact lenses like MiSight provide a middle ground. They offer daytime freedom similar to Ortho-K but with the convenience of a disposable lens. No overnight wear, no cleaning solutions, just a fresh lens each morning. The 59% reduction in refractive progression is impressive, and the high satisfaction rates indicate children find them comfortable and easy to use. These lenses suit responsible children ages eight and older who want the social and practical benefits of contact lenses but prefer not to sleep in lenses. They are also a good fit for children with mild to moderate astigmatism, as the approved range includes up to negative 0.75 diopters.

Why Choose Atropine Eye Drops?

Low-dose atropine remains the simplest intervention from a physical handling perspective. One drop each night requires no lens insertion skills, no cleaning, and no overnight wear discomfort. The 50% to 60% efficacy is comparable to or better than optical treatments, and the safety profile is excellent. Atropine is often the first choice for very young children under six, for kids with contact lens intolerance, or as an adjunct therapy for aggressive progressors. However, because it does not correct vision, children still need daytime glasses or contacts, meaning it does not reduce the overall burden of vision correction.

What Are the Advantages of Stellest Glasses?

Stellest lenses offer unmatched simplicity and broad applicability. Children ages six to twelve who already wear glasses can transition seamlessly to Stellest without learning new skills or changing routines. The 71% reduction in refractive progression rivals or exceeds the other modalities, particularly when compliance is high. The key is consistent wear, at least 10 to 12 hours per day, six days per week. For families with young children, those with sensory sensitivities, or those seeking the path of least disruption, Stellest is often the most practical and effective choice. It also works well for children who may transition to contact lenses later, providing a bridge treatment during the early school years when progression is often fastest.

The Role of Lifestyle: Outdoor Time and Screen Management

No discussion of myopia management is complete without addressing lifestyle factors. While optical and pharmacological treatments slow progression, environmental modifications provide additional protective effects and address root causes of the modern myopia epidemic.

Why Does Outdoor Time Matter?

Children today spend an average of four to seven minutes per day in unstructured outdoor play, while logging more than seven hours daily on screens. Preschool children average 32 hours per week with screen media. This dramatic shift from outdoor to indoor, near-focused environments drives much of the epidemic. Natural light triggers dopamine release in the retina, which signals the eye to stop elongating. Outdoor time functions like a vitamin for visual development, with research suggesting that a minimum of 90 to 120 minutes per day outdoors provides protective benefit. Even in winter months, daylight exposure matters. The intensity and spectrum of natural light, not warmth or physical activity alone, deliver the therapeutic effect.

How Can Families Increase Outdoor Exposure?

Parents should view outdoor time as medicine, not optional recreation. Scheduling outdoor breaks before school, during recess, after school, and on weekends adds up quickly. Walking to school, playing in the backyard, eating lunch outside, and engaging in outdoor sports all contribute. The goal is cumulative exposure, so even fragmented periods throughout the day provide benefit.

What About Screen Time Limits?

Screen time management complements outdoor exposure. The 20-20-20 rule, recommended by the American Optometric Association, advises that every 20 minutes spent on near work, children should look at least 20 feet away for 20 seconds. This gives the focusing muscles a break and reduces strain. While screens are not the sole driver of myopia, excessive near work without breaks does contribute. Balancing screen time with outdoor time, ensuring good lighting during close work, and encouraging breaks during homework sessions all support healthier visual development.

Monitoring Progress and Adjusting Treatment

How Often Should Children Have Follow-Up Visits?

Myopia management is not a one-time intervention but a multi-year journey requiring regular monitoring and adjustment. Children enrolled in treatment typically return for progress checks every six months. During these visits, the doctor measures visual acuity, refraction, and when indicated, axial length using specialized instruments. These data points track how quickly the eye is growing and whether the current treatment is delivering the expected slowdown.

What Happens If Progression Continues Too Fast?

If progression continues faster than anticipated despite good compliance, the treatment plan may be intensified. This could involve increasing atropine concentration, switching from Stellest to Ortho-K for stronger effect, or adding atropine to an existing optical treatment. Conversely, if progression slows dramatically or stops, the doctor may consider tapering treatment gradually to minimize rebound effects. These decisions are guided by both clinical data and the child’s age, as growth rates naturally slow as children approach their teenage years.

Addressing Common Parent Concerns

Will My Child Tolerate the Treatment?

Parents naturally have questions and concerns when considering myopia management. One frequent worry is whether their child will tolerate the treatment. For Stellest lenses, tolerance is generally high because they look and feel like regular glasses. Children look through the clear central zone for everyday tasks, and most adapt within days. For Ortho-K and contact lenses, the initial adjustment period varies, but studies show that the vast majority of children adapt quickly and express high satisfaction. Atropine drops may cause mild light sensitivity in bright sunlight during the first few months, but this resolves with sunglasses and typically diminishes over time.

How Much Does Myopia Management Cost?

Another concern is cost. Myopia management treatments are often premium services not fully covered by standard vision insurance. However, many practices offer flexible payment plans, and some families use Health Savings Accounts or Flexible Spending Accounts to offset costs. The value proposition is compelling. Preventing just one diopter of progression reduces lifetime disease risk by 20% to 67% depending on the condition. The cost of treatment over several years pales in comparison to the potential cost of retinal surgery, glaucoma management, or macular degeneration treatment decades later. Practices dedicated to myopia management often provide no-charge initial consultations to help families understand their options and make informed decisions.

Can We Switch Between Treatments?

Parents also wonder whether they must choose just one treatment or whether their child can switch modalities over time. The answer is that flexibility is built into modern myopia management. A child might start with Stellest at age six, transition to MiSight contact lenses at age ten when they are ready for lens handling, and later move to Ortho-K in their early teens if they become serious about a sport. Alternatively, a fast progressor might combine Stellest with low-dose atropine for maximum effect during peak growth years. The key is working with a clinician experienced in all modalities who can tailor and adjust the plan based on the child’s evolving needs.

Kids Vision Health The Long Term Consequences Of Myopia

The Importance of Early Intervention

Why Does Starting Early Matter So Much?

Timing matters profoundly in myopia management. The younger a child is when myopia begins, the more years they have ahead of them for progression, and the higher their ultimate prescription is likely to be. A child who becomes myopic at age six has six to eight years of active eye growth remaining, potentially accumulating several diopters by late adolescence. Each additional diopter compounds lifetime disease risk. Conversely, delaying myopia onset by even a few years, or slowing progression during the critical early years, dramatically reduces final prescription and associated risks.

What Happens If We Wait?

Parents sometimes adopt a wait-and-see approach, hoping their child’s myopia will stabilize on its own. Unfortunately, waiting is not neutral. Every year of delay costs diopters and increases risk. Children with progressive myopia are on a trajectory toward higher prescriptions unless intervention occurs. The evidence is clear that early intervention delivers the strongest benefit. Starting treatment when myopia is still mild preserves more of the eye’s natural structure and limits the cumulative damage from elongation.

Global Leadership and Local Expertise

What Should I Look for in a Myopia Management Practice?

Families seeking myopia management benefit from choosing practices with specialized training, research involvement, and access to all treatment modalities. Practices affiliated with national myopia management programs like Treehouse Eyes, or those whose doctors serve in leadership roles within professional organizations, bring cutting-edge protocols and rigorous outcome tracking to patient care. Doctors who have participated in clinical trials for Ortho-K, atropine, or specialty lenses understand not just the published data but the nuances of fitting, troubleshooting, and optimizing compliance.

Does Expertise Really Make a Difference?

Geographic access to specialized care varies, but families increasingly travel to practices recognized for leadership in the field. The unique credentials of fellowship-trained optometrists, those with advanced certifications in pediatric vision and specialty contact lenses, and those with personal or professional commitment to the mission of preserving children’s sight all signal a higher level of expertise and dedication. Parents should look for practices that offer comprehensive risk assessments, precise measurements for optical treatments, and structured follow-up protocols with axial length monitoring.

The Highest Rated Eye Care Center In Orange County

What Our Patients are Saying

“Insight vision has great customer service staff n the best optometrist Ive ever seen
Dr Nathan Schramm spends as much time as needed n has the highest advanced technology. I highly recommend this practice for anyone with any vision problem.”

⭐⭐⭐⭐⭐

Nancy B.

“Everyone there was really nice. From the front desk to the doctor, they were all very nice and accommodating. Rachel was the one who taught me how to put contact lenses in my eyes and she was super patient with me. Definitely recommend this place.”

⭐⭐⭐⭐⭐

Tim S.

Protect Your Child’s Vision: Take the First Step Today

The addition of Stellest spectacle lenses to the myopia management landscape gives families a fourth proven option, expanding access and flexibility in meaningful ways. No longer must parents choose between contact lens handling at young ages or relying solely on eye drops. Stellest provides a bridge, a highly effective optical treatment in a format that six-year-olds can use successfully with minimal disruption to daily routines.

Myopia is a progressive disease with serious long-term consequences, but it is also highly manageable when caught early and treated consistently. Orthokeratology, multifocal soft lenses, low-dose atropine, and Stellest spectacles each offer robust efficacy, and the optimal choice depends on the child’s age, lifestyle, prescription, and family preferences. The common thread across all modalities is that they work. Clinical trials involving thousands of children over years of follow-up demonstrate meaningful reductions in progression, translating directly into lower lifetime risks of retinal detachment, macular degeneration, glaucoma, and cataracts.

For parents navigating this landscape, the message is one of hope and empowerment. The tools exist to protect your child’s vision. The research supports intervention. The window of opportunity is now, during the active growth years when every diopter saved compounds over a lifetime. Whether your child thrives with the simplicity of Stellest glasses, the freedom of Ortho-K, the convenience of daily disposable lenses, or the pharmaceutical support of atropine, a path forward exists. And for many children, that path may shift over time, adapting as they grow and their needs evolve.

The expansion of choices in myopia control reflects the maturation of the field. What was once a niche area of optometry is now a central focus of pediatric eye care, driven by epidemic-level prevalence and the recognition that progressive myopia is not benign. Every family deserves access to accurate information, comprehensive evaluation, and the full range of treatment options. With Stellest joining the ranks of proven interventions, that access has never been broader. The future of your child’s vision is not predetermined. It is a choice, and that choice begins with a single conversation, a single examination, and a commitment to protecting the gift of sight for decades to come.

Schedule Your No-Charge Myopia Evaluation Today

Every month of delay allows your child’s myopia to progress unchecked, adding diopters that increase their lifetime risk of serious eye disease. The earlier we intervene, the more vision we preserve and the safer their visual future becomes. Our comprehensive myopia evaluation includes risk assessment, precise measurements, and a personalized treatment plan tailored to your child’s unique needs. This evaluation is complimentary, with no obligation, because we believe every parent deserves to understand their options and make informed decisions about their child’s eye health. Contact our Myopia Management Care Coordinator today for a free phone consultation, or schedule your child’s evaluation online. Your child’s eyes are growing right now. Let’s make sure they’re growing in the right direction.

Insight Vision Center Optometry is a proud member of Vision Source, the premier network of private practice optometrists.

Our Testimonials

Real experiences from clients who’ve seen our expertise—discover what our patients have to say.

Dr. Chen and the staff are very friendly and professional and can provide patients with sincere service and advice.

Elise Fu

Insight Vision Center Optometry has truly transformed my eyecare experience over the past year. Under the expert care of Dr. Chen, Dr. Schramm, Dr. Lam, and Dr. Mai, I've received unparalleled attention and personalized service. Their commitment to excellence extends beyond the doctors to the outstanding admin and tech team who ensure a seamless... Read more

Nathaniel Choi

Dr. Mai and the entire personnel are amazing! Extremely polite, kind and professional. In addition, I can now see 20/20!!! Thank you, thank you all

Franchezka 777

Dr. Schramm is stellar. He really cares about his patients. Great staff. Scleral lenses are life changing.

Kevin W

My first eye exam in fifteen years. I am so thankful that I found Insight Vision Center. Dr. Lam and staff made me feel like a welcome guest. My eye exam revealed very minor blurriness and Dr. Lam did not pressure me into purchasing eyewear for a condition not necessitating glasses… yet. Maybe next... Read more

Scott H.

Dr. Lam and staff are amazing. Every phone call or interaction is friendly. You can feel the smiles and joy over whatever mode of communication you are interacting with them. Dr. Lam is very knowledgeable and helps you to better understand everything that is going on with your eyes. She made me aware of... Read more

Virgilio S.